U.S. patent application Ser. No. 10/142,737, Barta et al., filed May 10, 2002. |
U.S. patent application Ser. No. 09/989,943, Barta et al., filed Nov. 21, 2001. |
U.S. patent application Ser. No. 09/311,837, Barta et al., filed May 14, 1999. |
U.S. patent application Ser. No. 09/570,731, (same disclosure as WO 00/69821), Barta et al., filed May 12, 2000. |
U.S. patent application Ser. No. 09/554,082, (same disclosure as WO 99/25687), Barta et al., filed May 12, 2000. |
U.S. patent application Ser. No. 09/191,129, (Publ. No. 2001/0014688), Barta et al., filed Nov. 13, 1998. |
Brown, “Synthetic Inhibitors of Matrix Metalloproteinases”; Matrix Metalloproteinases, pp. 243-261 (Academic Press, Eds Parks, W.C., & Mecham, R.P., 1998). |
Tang, ADAMTS: a novel family of extracellular matrix proteases, The International Journal of Biochemistry & Cell Biology 33 (2001) pp. 33-44. |
Woessner, “The Matrix Metalloproteinase Family”, Matrix Metalloproteinases, pp. 1-14 (Academic Press, Eds Parks, W.C., & Mecham, R.P., 1998). |
Gearing et al. Nature, 370, 555-557 (1994). |
McGeehan et al., Nature 370, 558-561 (1994). |
Mitchell et al., J. Clin. Invsest., 97(3) 761-768 (1996). |
Reboul et al., J. Clin Invest., 97(9), 2011-2019 (1996). |
Schwartz et al., Progr. Med. Chem., 29:271-334 (1992). |
Rasmussen et al., Pharmacol. Ther., 75(I): 69-75 (1997). |
Denis et al., Invest. New Drugs, 15, 175-185 (1997). |
Kenyon, BM, et al., Investigative Ophthalmology & Visual Science, vol. 37, No. 8 (Jul. 1996). |
Knight et al., FEBS Lett. 296(3):263-266 (1992). |
Luckow et al., J. Virol., 67(8):4566-4579 (1993). |
McClure et al. “Matrix metalloprotease . . . ” CA 131:125454 (1999). |
Dack et al. “Preparation of N-hydroxytetrahydro . . . ” CA 131:44740 (1999). |